Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the free cash flow yield high or low?
The free cash flow yield of 3.76% is in line with its estimated 1-year average of 3.56%, near the high end of its estimated 1-year range (3.22%–3.91%).
As of 2026-10-06T18:21:39.041Z.
Calculation as of: 2026-10-06T18:21:39.041Z.
Quote observation: 2026-10-06T17:49:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8dac276dab9b72f767ef95dff0a018bdb1655164ea652fec6d95688d7a2c4747
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
3.76%
FREE CASH FLOW YIELD AVG TTM
N/A
FREE CASH FLOW YIELD AVG 3Y
N/A
FREE CASH FLOW YIELD AVG 5Y
N/A
FREE CASH FLOW YIELD AVG 10Y
N/A
FREE CASH FLOW YIELD AVG 15Y
N/A
FREE CASH FLOW YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.72%
median of 208 covered companies
CURRENT VS SECTOR MEDIAN
-20.34%
vs the sector median at left
Vyome Holdings, Inc.
Market Cap
$13.93M
Free Cash Flow Yield
3.76%
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| Vyome Holdings, Inc. (HIND) | $13.93M | 3.76% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.78M | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.01M | N/A |
| Passage Bio, Inc. (PASG)vs › | $13.40M | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.33M | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.48M | N/A |
| IN8bio, Inc. (INAB)vs › | $13.33M | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.92M | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.73M | N/A |
FCF Yield
3.76%
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2026-10-05 | 3.87% |
| 2026-10-02 | 3.91% |
| 2026-10-01 | 3.89% |
| 2026-09-30 | 3.87% |
| 2026-09-29 | 3.70% |
| 2026-09-28 | 3.68% |
| 2026-09-25 | 3.66% |
| 2026-09-24 | 3.63% |
| 2026-09-23 | 3.72% |
| 2026-09-22 | 3.83% |
| 2026-09-21 | 3.87% |
| 2026-09-18 | 3.56% |
| 2026-09-17 | 3.81% |
| 2026-09-16 | 3.83% |
| 2026-09-15 | 3.72% |
| 2026-09-14 | 3.63% |
| 2026-09-11 | 3.63% |
| 2026-09-10 | 3.56% |
| 2026-09-09 | 3.63% |
| 2026-09-08 | 3.58% |
| 2026-09-04 | 3.37% |
| 2026-09-03 | 3.35% |
| 2026-09-02 | 3.43% |
| 2026-09-01 | 3.44% |
| 2026-08-31 | 3.46% |
| 2026-08-28 | 3.38% |
| 2026-08-27 | 3.38% |
| 2026-08-26 | 3.46% |
| 2026-08-25 | 3.35% |
| 2026-08-24 | 3.34% |
| 2026-08-21 | 3.32% |
| 2026-08-20 | 3.28% |
| 2026-08-19 | 3.22% |
| 2026-08-18 | 3.29% |
| 2026-08-17 | 3.29% |
| 2026-08-14 | 3.43% |
| 2026-08-13 | 3.46% |
